TriPair is the solution for tricuspid interventions Tricuspid regurgitation (TR) is a life-threatening condition that can lead to heart failure, end-organ damage such as liver failure, repeated hospitalizations, and death. Many millions suffer from moderate or severe TR, and the three-year survival rate for severe cases is less than 50%. The Coramaze TriPair System brings healing to patients without access to alternative therapies.